|
KMID : 1022820100010020059
|
|
Journal of Multiple Sclerosis and Neuroimmunology
2010 Volume.1 No. 2 p.59 ~ p.63
|
|
|
Successful Treatment of Neuromyelitis Optica with Rituximab
|
|
Noh Hyun-Du
Park Min-Su
|
|
|
Abstract
|
|
|
|
Neuromyelitis optica (NMO) is an idiopathic inflammatory disorder of the central nervous system. Clinical, laboratory, and immunologic features suggest that NMO is a humorally mediated disease and B cell targeted therapy is ideal and effective treatment in NMO. We describe a 35-year-old woman with NMO, who suffered from very frequent attacks despite the maintenance of long-term prednisolone therapy, dramatically responded to rituximab.
|
|
|
KEYWORD
|
|
|
Neuromyelitis optica, Rituximab
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|